Sign in with Google. Opens in new tab
Tigermed (泰格医疗) A+H: PHIP Updates and Thoughts on Valuation
570 Views20 Jul 2020 10:52
Hangzhou Tigermed, a leading China-based CRO company, is seeking a USD 1.5 bn H-share listing in Hong Kong. In our previous note, we discussed that...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- SK Square: Time to Take Profits + Why Are There Holdco Discounts in the First Place?
- KOSPI Size Indices: Overlaps Between Active & Passive Flows
- Johns Lyng (JLG AU): PEP's A$4/Share Offer Looks Light
- Ohayo Japan | Markets Climb as Nvidia, Bitcoin Soar
- SBI Possible US$3bn QIP - Will Be One of the Largest Fund Raisings in India, Last One Didn’t Do Well
Top Unpaywalled Insights
More »- De-Dollarisation Debate : Unmasking USD Over-Valuation
- US Equities Hit All-Time Highs—but Are Markets Ignoring Growing Risks?
- Why America's Manufacturing Dreams Might Be Economic Nightmares
- Systematic Global Macro: Data, AI, and Models Are Reshaping Investing | New Barbarians AI Agent #05
- China Housing - A Mid-Year Check
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Tigermed (泰格医疗) A+H Trading: Insti Buying to Continue Post Listing06 Aug 2020
- Tigermed (泰格医疗) A+H: Past A+H Listings Suggest Upside Might Be Limited27 Jul 2020
- Tigermed (泰格医疗) A+H: PHIP Updates and Thoughts on Valuation20 Jul 2020
- Tigermed (泰格医疗) A+H Listing: Hot Deal of the Best China Clinical-CRO Play26 Apr 2020
x